Gara Jalqabaatti › Melanoma › North Carolina › Durham
Qorannoo klinikaalii Melanoma Durham, NC keessatti
Qorannoo 21 Melanoma f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
Namoota walitti qabaa jiraSadarkaa 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Namoota walitti qabaa jiraSadarkaa 3
- Duke Health System, Durham
DESTINY-PANTUMOUR04
Namoota walitti qabaa jiraQorannoo ilaalaa
- Research Site, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Namoota walitti qabaa jiraSadarkaa 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Namoota walitti qabaa jiraQorannoo ilaalaa
- UNC- Chapel Hill, Chapel Hill · Miili 10 fagaatti
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina, Chapel Hill · Miili 10 fagaatti
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · Miili 10 fagaatti
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
Namoota walitti qabaa jiraSadarkaa 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Namoota walitti qabaa jiraSadarkaa 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Namoota walitti qabaa jiraSadarkaa 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Namoota walitti qabaa jiraSadarkaa 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Namoota walitti qabaa jiraSadarkaa 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chapel Hill · Miili 10 fagaatti
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Namoota walitti qabaa jira
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Namoota walitti qabaa jira
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · Miili 13 fagaatti
Qorannoo Melanoma magaalota biroo keessatti
- Houston, TXQorannoo 59
- New York City, NYQorannoo 38
- Los Angeles, CAQorannoo 34
- Nashville, TNQorannoo 33
- Pittsburgh, PAQorannoo 31
- Boston, MAQorannoo 26
- Philadelphia, PAQorannoo 23
- San Francisco, CAQorannoo 22
- Columbus, OHQorannoo 21
- Atlanta, GAQorannoo 21
- Salt Lake City, UTQorannoo 21
- St. Louis, MOQorannoo 21
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.